Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma.

@article{Kidner2012CombinedIB,
  title={Combined intralesional Bacille Calmette-Gu{\'e}rin (BCG) and topical imiquimod for in-transit melanoma.},
  author={Travis B Kidner and Donald L. Morton and Delphine J. Lee and Mary Beth Hoban and Leland J. Foshag and Roderick R. Turner and Mark B Faries},
  journal={Journal of immunotherapy},
  year={2012},
  volume={35 9},
  pages={716-20}
}
The introduction of numerous immunotherapeutic agents into the clinical arena has allowed the long-time promise of immunotherapy to begin to become reality. Intralesional immunotherapy has demonstrated activity in multiple tumor types, and as the number of locally applicable agents has increased, so has the opportunity for therapeutic combinations. Both intralesional Bacille Calmette-Guérin (ILBCG) and topical 5% imiquimod cream have been used as single agents for the treatment of dermal… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

Similar Papers

Loading similar papers…